Fundamentals of Clinical Trials by Lawrence M. Friedman  (8)  $58.40

› Explore similar items : Books (1)

Product Description
Designing a drug development program or key study can be a daunting task due to growing limitations on time and resources in industry and in academia. Scientific advances and increasing competition in the drug development arena demand a quick, easy-to-use source of data. The Handbook of Phase I/II Clinical Drug Trials is that source. It is an indispensable guide, readily providing the information needed to make crucial decisions regarding drug therapies. This book makes it easy to plan cost-effective, early drug development programs. The first four sections of the text deal with the preliminaries to studying drugs in humans, as well as considerations common to early drug trials in human subjects. Part II considers organization and decision making factors. Ethical and legal considerations are discussed in the next section. Subsequent chapters deal with specific therapeutic areas and indications. Areas of growing importance, such as studying in vitro metabolism in human hepatocytes and genetic engineering are highlighted as well. The Handbook of Phase I/II Clinical Drug Trials is your complete guide to successful early drug development.

Book Info
Daiichi Pharmaceuticals U.K. Ltd., London, England. Revised edition of: Early Phase Drug Evaluations in Man (1990). Focuses on effective and rapid initial investigations of the properties of new drugs in humans. 67 contributors, 20 U.S. DNLM: Drug evaluation.

First Sentence:
The primary goal of most research-based pharmaceutical organizations around the world is to discover, develop, and procure necessary regulatory approvals for marketing new drugs for the treatment or prevention of diseases in humans and animals. Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
new antiparkinsonian drugs, early patient studies, indicator dye dilution technique, claudication studies, scopolamine model, intermittant claudication, anthralin inflammation, drug disposition studies, unwanted drug effects, repeatability coefficient, computerized assessment system, antisecretory effect, antisecretory activity, healthy volunteer studies, clinical drug trials, antidepressant drug trials, antidementia drugs, cellular exfoliation, tolerability study, early phase studies, secondary pharmacology, new antibacterial agent, inhibition zone diameters, chronic viral illnesses, investigator costs Key Phrases - Capitalized Phrases (CAPs): (learn more)
Handbook of Phase, New York, Department of Health, Agents Chemother, Royal College of Physicians, Declaration of Helsinki, Raven Press, European Commission, Medicines Act, Pharmacodynamic Issues, World Health Organization, Drug Metab, Medical Research Council, North America, Acta Derm, Marcel Dekker, Mueller Hinton, Academic Press, Acta Psychiatr, American Heart Association, Dermatology Volume, Government Printing Office, Handbook of Experimental Pharmacology Vol, Martinus Nijhoff, Oxford University Press New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Copyright | Table of Contents | Excerpt | Index | Back Cover | Surprise Me!

Search Inside This Book: